Eli Lilly appoints Lucas Montarce as CFO to meet rising demand for diabetes and weight loss drugs.

Eli Lilly has appointed Lucas Montarce as Chief Financial Officer, effective immediately, following the departure of Anat Ashkenazi. Montarce, a company veteran since 2001, previously served as Senior VP of Global Controller. His appointment comes as Lilly invests significantly in expanding its manufacturing to meet rising demand for diabetes and weight loss drugs. Analysts predict the market for such medications could exceed $150 billion by the early 2030s.

September 09, 2024
14 Articles